Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®)

Journal of Controlled Release

Volumn 80, Issue 1-3, 2002, Pages 129-144

  Mu, L ^a   Feng, S S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anticancer drugs; Drug encapsulation efficiency; Nanoparticles; PLGA; Surfactant stabiliser

Indexed keywords

DEXTRO ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE; EMULSIFYING AGENT; MACROGOL; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROMETRY; LIGHT SCATTERING; MORPHOLOGICAL TRAIT; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; SURFACE PROPERTY; THERMOGRAPHY; X RAY PHOTOELECTRON SPECTROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; MICROSPHERES; NANOTECHNOLOGY; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYMERS; SOLVENTS; VITAMIN E;

EID: 0037161315     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00025-1     Document Type: Article

References (31)

1. Biodegradable polymeric nanoparticles as drug delivery devices
2. A method for the preparation of polymeric nanocapsules without stabilizer
3. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers
4. Multicenter trial of d-α-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis
5. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)
6. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability
7. The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment
8. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion
9. The effect of water-soluble vitamin-E (TPGS) on oral cyclosporine pharmacokinetics in healthy volunteers
10. Controlled release of bioactive agents from lactide/glycolide polymers
11. Plant antitumor agents. VI: The isolation and structure of Paclitaxel. A novel anti leukemic and antitumor agent from Taxus brevifolia
12. Measurement of cremopnor EL following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype
13. Is cremophor, solvent for paclitaxel, cytotoxic?
14. Pharmacology and toxicology of Cremophor EL diluent
15. Interaction of Cremophor-EL with human plasma
16. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation
17. Acute effects of cyclosporine and cremophor EL on endothelial function and vascular smooth-muscle in the isolated rat-heart
18. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials
19. Production and evaluation of orally administered insulin nanoparticles
20. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
21. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine
22. Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, Taxol
23. Thermoanalysis of microspheres
24. Evidence for preferential surface enrichment in the surface chemical analysis of a series of poly(butyl methacrylate co-methyl methacrylate) latices using X-ray photoelectron spectroscopy and static secondary ion mass spectrometry
25. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
26. Use of plasma glow for surface-engineering biomolecules to enhance blood compatibility of Dacron and PTFE vascular prosthesis
27. Biodegradable polymers